Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations
- 1 October 1997
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 273 (4) , H1769-H1774
- https://doi.org/10.1152/ajpheart.1997.273.4.h1769
Abstract
The current study examined the contributions of angiotensin-converting enzyme (ACE) vs. chymase to angiotensin II (ANG II) generation in membrane preparations from left ventricles of humans, dogs, rabbits, and rats and from total heart of mice. ACE and chymase activity were measured in membrane preparations extracted with low or high detergent (LD and HD, respectively) concentrations. We hypothesized that ACE, which is membrane bound in vivo, would be preferentially localized to the HD preparation, whereas chymase, which is localized to the cytoplasm and cardiac interstitium, would be localized to the LD preparation. In human heart, ACE activity was 16-fold higher in the HD than in the LD preparation, whereas chymase activity was 15-fold higher in the LD than in the HD preparation. Total ANG II formation was greater in human heart [15.8 ± 3.4 (SE) μmol ANG II ⋅ g−1⋅ min−1] than in dog, rat, rabbit, and mouse hearts (3.90 ± 0.35, 0.41 ± 0.02, 0.61 ± 0.07, and 1.16 ± 0.08 μmol ANG II ⋅ g−1⋅ min−1, respectively, P < 0.05, by analysis of variance). ANG II formation from ACE was higher in mouse heart (1.09 ± 0.05 μmol ANG II ⋅ g−1⋅ min−1, P < 0.001) than in rabbit, human, dog, and rat hearts (0.55 ± 0.06, 0.34 ± 0.01, 0.32 ± 0.06, and 0.31 ± 0.02 μmol ANG II ⋅ g−1⋅ min−1, respectively). In contrast, chymase activity was higher in human heart (15.3 ± 3.4 μmol ANG II ⋅ g−1⋅ min−1) than in dog, rat, rabbit, and mouse hearts (3.59 ± 0.29, 0.10 ± 0.01, 0.06 ± 0.01, and 0.07 ± 0.01 μmol ANG II ⋅ g−1⋅ min−1, respectively). Our results demonstrate important species differences in the pathways of intracardiac ANG II generation. Chymase predominated over ACE activity in human heart, accounting for extremely high total ANG II formation in human heart compared with dog, rat, rabbit, and mouse hearts.Keywords
This publication has 26 references indexed in Scilit:
- Angiotensin II-Forming Activity in a Reconstructed Ancestral ChymaseScience, 1996
- Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.Journal of Clinical Investigation, 1995
- Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.Hypertension, 1994
- Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling.Hypertension, 1994
- Role of Angiotensin in Pressure Overload-Induced Hypertrophy in RatsJournal of Cardiovascular Pharmacology, 1994
- Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitroCell, 1993
- Beneficial effects of a serine protease inhibitor in peripheral vascular diseaseThe American Journal of Cardiology, 1993
- Microinjection of α-Calcitonin Gene-Related Peptide into the Hypothalamus Activates Sympathetic Outflow in RatsThe Japanese Journal of Pharmacology, 1993
- Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.Journal of Clinical Investigation, 1990
- Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypothesesJournal Of Hypertension, 1989